We’re only four months into 2022, and it’s clear the year ahead is going to be just as bumpy and unpredictable for life sciences organizations as 2021 was.

All signs point to a waning of the two-year-old COVID-19 pandemic, but there’s no shortage of new uncertainties impacting health care, global trade, and innovation.

Recently, life sciences market experts from Advisory Board and Optum Life Sciences came together to consider the trends poised to have the greatest impact on the market for life sciences data and evidence in 2022. Drawing on conversations with 200+ decision-makers across the health care ecosystem—as well as a series of executive roundtables and cross-industry events for life sciences medical, health economics and outcomes research (HEOR), and market access leaders—we identified 11 trends worth watching this year.